Dec 30, 2025
FDA approves Nufymco as biosimilar to Lucentis
By: Anthony DeFino Fact checked by: Eamon N. Dreisbach Key takeaways: Nufymco is indicated for the treatment of patients with …
Resources
Dec 22, 2025
Light Therapy for Dry AMD: What Do We Know?
Newly authorized treatment has fans, but skepticism persists amid sparse data by Randy Dotinga, Contributing Writer, MedPage Today December 19, 2025 …
Dec 19, 2025
Can a retinal implant reverse macular degeneration?
Researchers at the USC Roski Eye Institute, part of Keck Medicine of USC, are launching a phase 2b clinical trial examining if stem cells …
Dec 18, 2025
Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration
by: Julie Poteet, Cecelia Koetting & Priya S. Vakharia Abstract No current treatments are curative for age-related macular degeneration (AMD), and preventing …
Dec 18, 2025
Holiday Break
Dear friends, We want to let you know that the Macular Degeneration Association will be taking a short holiday break! …
Dec 15, 2025
Regeneron Pharmaceuticals is currently sponsoring a clinical trial enrolling patients with geographic atrophy (GA) who qualif
Regeneron has partnered with The Foundation Fighting Blindness to raise awareness about an ongoing clinical trial investigating subcutaneously administered investigational …
Dec 9, 2025
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
Author(s): Martin David Harp Key Takeaways Xelafaslatide, a Fas inhibitor, shows promise in protecting retinal cells and slowing GA progression …
Dec 9, 2025
Supporting eye health through a holistic approach to full-body health
Author(s):Vittorio Mena, OD, MS, Fact checked by: Matt Hoffman, Kirsty Mackay Our patients benefit from a preventive approach that includes lifestyle adjustment, …
Dec 9, 2025
Majority of US patients with dry eye experience symptoms weekly, survey finds
Author(s): Jordana Joy, Associate Editor Fact checked by: Ron Panarotti The survey was conducted by OnePoll on October 2025 and included …
Dec 3, 2025
Thank you-#GivingTuesday
Thank you to all who participated in yesterday’s # GivingTuesday. Your support fuels vital research and inspires hope for a …
Dec 1, 2025
Judi Dench Says She ‘Can’t Recognize Anybody’ Due to Eye Condition: ‘I Can’t See Anymore’
by: Jack Dunn Judi Dench recently shared that she “can’t recognize anybody” due to her eye condition. When asked by ITV why she’s …
Dec 1, 2025
#GivingTuesday 2025
Join us for #GivingTuesday2025 on Tuesday, December 2nd, from 12:00 AM to 11:59 PM! Your generous support can make a …
Nov 26, 2025
Happy Thanksgiving
Happy Thanksgiving! The Macular Degeneration Association would like to express our gratitude for your support and thoughtfulness. “As we show …
Nov 26, 2025
Low Vision vs Legally Blind: What’s the difference?
Dr. Long, thank you for explaining the difference between low vision and legal blindness. Low vision vs. legally blind—what’s the …
Nov 25, 2025
New Stem Cell Therapy Trial Offers Hope for Millions Living with Untreatable Advanced Dry Macular Degeneration
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no …
Nov 25, 2025
FDA approves Eylea HD for macular edema after retinal vein occlusion
By: Anthony DeFino Fact checked by: Nancy Hemphill, ELS, FAAO Key takeaways: The decision is supported by positive visual acuity …
Nov 24, 2025
GLP-1s may double risk for development of wet AMD
By Justin Cooper Fact checked by; Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher …
Nov 24, 2025
EYE on MACULAR CAROTENOIDS: Diet & Supplementation
You’ve heard of Vitamin A for your eyes… but did you know there’s a family of natural pigments that may …
Nov 21, 2025
8 Foods That Fight Inflammation Even Better Than Ginger
By Anna Giorgi Published on November 18, 2025 Medically reviewed by Karina Tolentino, RD Ginger is one of several foods that may …
Nov 18, 2025
Enjoying the Winter Wonderland: A Winter Eyecare Guide
As winter sets in, many of us may experience symptoms that differ from those in other times of the …
Nov 18, 2025
Apellis announces 5-year GALE study data in GA
Author(s): Kassi Filkins Fact checked by: Kirsty Mackay Key Takeaways SYFOVRE (pegcetacoplan injection) delays GA lesion growth by approximately 1.5 years …
Nov 17, 2025
The Eye Q Podcast Episode 49
In this episode of The Eye-Q Podcast, Dr. Rani Banik sits down with Dr. Debbie Ozment—an integrative dentist with over …
Nov 11, 2025
Happy Veterans Day
Happy Veterans Day. Thank you to all who serve and their families for their sacrifices. “As we express our gratitude, …
Nov 7, 2025
eSight Go headset ‘gives you your central perception back’
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: eSight Go uses two OLED screens to boost visual …
Nov 6, 2025
GLP-1s may double risk for development of wet AMD
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher …
Nov 5, 2025
Smart eye wear ‘definitely having a moment’ with jump in consumer awareness
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Consumers are more familiar with smart eye wear than …
Nov 4, 2025
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
Author(s) : Martin David Harp Key Takeaways AXPAXLI is a bioresorbable hydrogel incorporating axitinib, targeting wet AMD and other retinal diseases …
Oct 30, 2025
Research supports that iron dysregulation may drive AMD
Author(s): Sydney M Crago Key Takeaways Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry …
Oct 24, 2025
Starting from scratch on neovascular age-related macular degeneration
Author(s): Lynda Charters Key Takeaways Gene therapy for nAMD offers potential to reduce treatment burden and improve vision, but long-term …
Oct 16, 2025
Consumer technology has limitations for assistive needs
By: Roland Mattern Fact checked by: Christine Klimanskis, ELS Key takeaways: Accessibility features in mainstream technology are not as reliable …